Prep for USMLEPrep for USMLE Forum
   Forum    Step 1  Step 2 CK Step 2 CS Step 3  Match  IMGs Resources Search






Previous Topic | Next Topic  Genetics 7 




 
Kaplan Qbank USMLE



Author5 Posts
  #1

Which is the gene mutation least likely to result in haemochromatosis?


  • Heterozygous his (H63D)
  • Heterozygous cys (C282Y)
  • Combined his (H63D) & cys (C282Y)
  • Homozygous cys
  • Homozygous his


    ___________________
    FORUM RULES-- Those who believe in telekinesis, raise my hand. I get enough exercise just by pushing my luck --P4U World.." The pure and simple truth is rarely pure and never simple."

  •   #2

    rolling eyes

      #3

    shockedconfused


    ___________________
    FORUM RULES-- Those who believe in telekinesis, raise my hand. I get enough exercise just by pushing my luck --P4U World.." The pure and simple truth is rarely pure and never simple."

      #4

    raised eyebrow

      #5

    I know I know this one was a Purely Research Question Well here is the Info anyways.

    Heterozygous his (H63D)


    The gene identified by Feder and colleagues (1996) ("HLA-H" but now defined as HFE) lies approximately 5Mb telomeric to HLA-A and shows similarity to MHC class 1 genes. A single mutation is associated with HHC in 65 to 100 percent of cases.


    The mutation is a G to A transition at nucleotide 845 and results in the substitution of cysteine with tyrosine at position 282 (C282Y) and disruption of a disulphide bridge required to stabilise the protein. A second mutation, a C to G change causing a histidine to aspartic acid substitution at position 63 (H63D) was also identified.

    Recent data from numerous countries have confirmed that the C282Y mutation is primarily responsible for the large majority of HLA-linked HHC cases. The figures range from approximately 95 percent in <?xml:namespace prefix = st1 ns = "urn:schemas-microsoft-com:office:smarttags" />Australia to 90 percent in Great Britain, 80 percent in the United States to 60 percent in Italy. The higher values are found in populations of Northern European extraction, the lower percentage in patients of Southern European (Mediterranean) extraction. (Jazwinska et al, 1996; Carella et al, 1996). Thus it must be emphasised that a varying proportion (10 to 40 percent) do not carry either mutation, and clinicians should not be misled into believing that patients who are not homozygous for the C282Y mutation do not have HHC. A small proportion (approximately 7 percent) of HHC cases are compound heterozygotes (i.e., carrying one copy of each of the C282Y and H63D mutations). Non-HFE-associated familial haemochromatosis has been described recently from Italy (Carella et al, 1997) and it is now established that the juvenile form of haemochromatosis, while clinically closely resembling the adult form, but occurring in the second and third decades of life, is not due to this mutation; nor are African iron overload or neonatal haemochromatosis.


    There is emerging clinical evidence to suggest that the second mutation (H63D) has a significant independent role in causing iron overload although this is usually of mild to moderate degree. Thus, compound (C282Y/H63D) heterozygotes may develop iron overload of a degree previously recognised as consistent with homozygous HLA-associated HHC, although as a group they do not have as severe iron overload as C282Y homozygotes (Crawford et al, 1998). The H63D mutation appears to have both low penetrance and comparatively low expressivity.

    The molecular basis of the iron overload due to these two mutations is rapidly being elucidated. In cultured cells, the wild-type HFE protein associates with the transferrin receptor and lowers the affinity of this receptor for transferrin. 2 microglobulin and thebThe C282Y mutation prevents the complexing of HFE with protein therefore accumulates in the endoplasmic reticulum and does not emerge to the cell surface and does not associate with the transferrin receptor (TfR). The H63D mutation in contrast lacks the ability of the wild-type HFE protein to decrease the affinity of TfR for transferrin (Feder et al, 1998). Thus, the two mutations have independent effects on iron metabolism relating to the affinity of TfR for transferrin on the cell surface.


    ___________________
    FORUM RULES-- Those who believe in telekinesis, raise my hand. I get enough exercise just by pushing my luck --P4U World.." The pure and simple truth is rarely pure and never simple."







    You don't have permission to post.




    Login or Register to post messages in this topic





















    Contact | Leaders | Disclaimer | Privacy

    Copyright @ Prep for USMLE. All rights reserved.